A clinical study that was conducted recently, found out that vitamin D supplements can reduce lung disease flare-ups by over 40 percent in patients having vitamin D deficiency.
Vitamin D deficiency is mostly found as a prevalent problem that persists the general population. There are no specific reasons being identified as to why there is an increased risk for vitamin D. The most prone people are the ones who have diseases such as asthma, cystic fibrosis, pneumonia and other related obstructive lung diseases.
Several studies indicate that vitamin D possesses a range of anti-inflammatory properties and may be involved in processes other than the previously believed functions of calcium and phosphate homeostasis.
The most usual symptoms found in the patients with COPD (Chronic obstructive pulmonary diseases) are coughing, shortness of breath, excessive mucous production and tightness in chest. This is the first clinical trial to investigate the impact of vitamin D supplementation on severity and duration of COPD symptoms.
The trial included 240 patients with COPD in and around London. Some most common chronic lung diseases namely asthma and other related lung diseases.
The study also depicts that the immune and genetic influence of Vitamin D may influence the pathogenesis of chronic lung diseases.